Wide Ranks

EPIX

ESSA Pharma Inc.

1.79

Top Statistics
Market Cap 79 M Forward PE -2.70 Revenue Growth 0.00 %
Current Ratio 36.95 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 130 M Total Cash Per Share 2.95 Total Debt 342142
Total Debt To Equity 0.2660 Current Ratio 36.95 Book Value Per Share 2.90
All Measures
Short Ratio 36.00 % Message Board Id finmb_275296588 Shares Short Prior Month 1 M
Return On Equity -0.1983 City Vancouver Uuid df985973-70f3-3299-9207-8f4fc74eed04
Previous Close 1.81 First Trade Date Epoch Utc 1 B Book Value 2.90
Beta 1.84 Total Debt 342142 Volume 202659
Price To Book 0.6164 Last Split Date 1 B Fifty Two Week Low 1.40
Total Cash Per Share 2.95 Shares Short Previous Month Date 1 B Target Median Price 2.96
Max Age 86400 Sand P52 Week Change 0.3133 Target Mean Price 13.20
Net Income To Common -27668952 Short Percent Of Float 0.0272 Implied Shares Outstanding 44 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 336780
Average Volume10days 336780 Total Cash 130 M Next Fiscal Year End 1 B
Held Percent Insiders 0.0226 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 1.81 Target Low Price 2.37
Gmt Off Set Milliseconds -18000000 Fifty Day Average 4.34 Open 1.79
Free Cashflow -16104563 State BC Dividend Yield 0.00 %
Return On Assets -0.1479 Time Zone Short Name EST Trailing Eps -0.6200
Day Low 1.78 Address1 999 West Broadway Shares Outstanding 44 M
Price Hint 4 Target High Price 44.53 Website https://www.essapharma.com
52 Week Change -0.6635 Average Volume 834887 Forward Eps -0.5000
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 3660.90 %
Last Split Factor 1:20 Regular Market Day High 1.85 Is_sp_500 False
Profit Margins 0.00 % Debt To Equity 0.2660 Fifty Two Week High 11.67
Day High 1.85 Shares Short 726535 Regular Market Open 1.79
Industry Key biotechnology Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0164 Operating Cashflow -23838482 Currency USD
Time Zone Full Name America/New_York Market Cap 79 M Is_nasdaq_100 False
Zip V5Z 1K5 Quote Type EQUITY Industry Biotechnology
Long Name ESSA Pharma Inc. Regular Market Day Low 1.78 Held Percent Institutions 0.8119
Current Price 1.79 Address2 Suite 720 Financial Currency USD
Current Ratio 36.95 Industry Disp Biotechnology Number Of Analyst Opinions 4
Country Canada Float Shares 20 M Two Hundred Day Average 5.98
Enterprise Value -50931872 Forward PE -2.70 Regular Market Volume 202659
Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.

The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer.

It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.